Feasibility and long-term outcomes of post-chemotherapy-based consolidation radiotherapy in extensive stage small-cell lung cancer

Ganti, 2021, Small cell lung cancer, Version 2.2022, NCCN Clinical practice guidelines in oncology, J Natl Compr Canc Netw, 19, 1441, 10.6004/jnccn.2021.0058 Siegel, 2021, Cancer Statistics, 2021, CA Cancer J Clin, 71, 7, 10.3322/caac.21654 Govindan, 2006, Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database, J Clin Oncol, 24, 4539, 10.1200/JCO.2005.04.4859 Noda, 2002, Japan Clinical Oncology Group. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer, N Engl J Med, 346, 85, 10.1056/NEJMoa003034 Lara, 2009, Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124, J Clin Oncol, 27, 2530, 10.1200/JCO.2008.20.1061 Hanna, 2006, Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer, J Clin Oncol, 24, 2038, 10.1200/JCO.2005.04.8595 Hermes, 2008, Irinotecan plus carboplatin versus oral etoposide plus carboplatin in extensive small-cell lung cancer: a randomized phase III trial, J Clin Oncol, 26, 4261, 10.1200/JCO.2007.15.7545 Paz-Ares, 2019, Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial, Lancet, 394, 1929, 10.1016/S0140-6736(19)32222-6 Horn, 2018, IMpower133 Study Group. First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer, N Engl J Med, 379, 2220, 10.1056/NEJMoa1809064 Goldman, 2021, Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial, Lancet Oncol, 22, 51, 10.1016/S1470-2045(20)30539-8 Slotman, 2007, Prophylactic cranial irradiation in extensive small-cell lung cancer, N Engl J Med, 357, 664, 10.1056/NEJMoa071780 Takahashi, 2017, Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial, Lancet Oncol, 18, 663, 10.1016/S1470-2045(17)30230-9 Simone, 2020, Radiation therapy for small cell lung cancer: an ASTRO clinical practice guideline, Pract Radiat Oncol, 10, 158, 10.1016/j.prro.2020.02.009 Slotman, 2015, Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial, Lancet, 385, 36, 10.1016/S0140-6736(14)61085-0 Yee, 2012, Clinical trial of post-chemotherapy consolidation thoracic radiotherapy for extensive-stage small cell lung cancer, Radiother Oncol, 102, 234, 10.1016/j.radonc.2011.08.042 Jeremic, 1999, Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: a randomized study, J Clin Oncol, 17, 2092, 10.1200/JCO.1999.17.7.2092 Slotman, 2017, Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: a secondary analysis of the Phase III CREST trial, Lung Cancer, 108, 150, 10.1016/j.lungcan.2017.03.007 Cai, 2018, The prognostic analysis of different metastatic patterns in extensive-stage small-cell lung cancer patients: a large population-based study, Future Oncol, 14, 1397, 10.2217/fon-2017-0706 Xie, 2015, Nomograms predict overall survival for patients with small-cell lung cancer incorporating pretreatment peripheral blood markers, J Thorac Oncol, 10, 1213, 10.1097/JTO.0000000000000585 Lee, 2021, Efficacy and safety of atezolizumab, in combination with etoposide and carboplatin regimen, in the first-line treatment of extensive-stage small-cell lung cancer: a single-center experience, Cancer Immunol Immunother, 1, 1093 Bang, 2018, Prophylactic cranial irradiation in extensive stage small cell lung cancer: outcomes at a comprehensive cancer centre, Int J Radiat Oncol Biol Phys, 101, 1133, 10.1016/j.ijrobp.2018.04.058 Yu, 2020, Prophylactic cranial irradiation for extensive-stage small cell lung cancer: analysis based on active brain MRI surveillance, Clin Transl Radiat Oncol, 25, 16 Formenti, 2013, Combining radiotherapy and cancer immunotherapy: a paradigm shift, J Natl Cancer Inst, 105, 256, 10.1093/jnci/djs629 Ko, 2018, The integration of radiotherapy with immunotherapy for the treatment of non-small cell lung cancer, Clin Cancer Res, 24, 5792, 10.1158/1078-0432.CCR-17-3620 Theelen, 2020, Synergizing systemic responses by combining immunotherapy with radiotherapy in metastatic non-small cell lung cancer: The potential of the abscopal effect, Lung Cancer, 142, 106, 10.1016/j.lungcan.2020.02.015